• All sections
  • C - Chemistrymetallurgy
  • C07D - Heterocyclic compounds
  • C07D 295/14 - Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals

Patent holdings for IPC class C07D 295/14

Total number of patents in this class: 148

10-year publication summary

4
4
4
4
4
10
8
7
0
0
2017 2018 2019 2020 2021 2022 2023 2024 2025 2026

Principal owners for this class

Owner
All patents
This class
Alnylam Pharmaceuticals, Inc.
1168
17
Daiichi Sankyo Company, Limited
1888
8
Takeda Pharmaceutical Company Limited
2721
7
Abbvie Inc.
1842
5
Astellas Pharma Inc.
1030
5
Toyama Chemical Co., Ltd.
93
5
Boehringer Ingelheim International GmbH
4510
4
Pfizer Inc.
3371
3
Abbott Laboratories
2289
3
Taisho Pharmaceutical Co., Ltd.
858
3
SK on Co., Ltd.
2126
3
Actavis Group PTC ehf
396
2
Arena Pharmaceuticals, Inc.
353
2
Bioprojet
44
2
Dainippon Sumitomo Pharma Co., Ltd.
174
2
Dongjin Semichem Co., Ltd.
492
2
Gifu University
126
2
Ideaya Biosciences, Inc.
146
2
Kyoto Pharmaceutical Industries, Ltd.
21
2
Kyoto University
2893
2
Other owners 67